Skip to content
Open access

Metabolic and Hormonal Predictors of Non-Alcoholic Fatty Liver Disease in PCOS/PMOS: A Clinicobiochemical Study

Aug 2026 · International Journal of Health Sciences and Research · pp. 38 · 0 citations · 20 references

TL;DR

A high prevalence of fatty liver and metabolic–hormonal disturbances in PCOS/PMOS is highlighted, primarily mediated by insulin resistance, hyperandrogenism and unhealthy dietary patterns, which underscore the necessity of early metabolic screening and lifestyle interventions.

Abstract

Introduction: PCOS, newly named PMOS (polyendocrine-metabolic-ovarian-syndrome) is now closely linked to NAFLD fueled by a toxic trifecta of insulin resistance, hormonal shifts and lifestyle choices, which frequently remains underdiagnosed among young PCOS patients in India. This study henceforth assessed the association between fasting insulin levels and ultrasonographically detected fatty liver in young Indian women with PCOS, alongside metabolic and dietary predictions. Methods: A hospital-based cross-sectional study was conducted among 384 women (aged 18-40) diagnosed with PCOS (Rotterdam criteria). Clinical, biochemical, anthropometric and dietary data were collected. Abdominal ultrasonography was used to detect the grade-level fatty liver. Statistical analysis included chi square tests, t-tests and logistic regression, with p<0.05 considered significant. Results: Fatty liver was present in 62.8% of participants (with PCOS). Elevated fasting insulin (>20 µIU/mL) showed a strong association with fatty liver (p<0.001). Women with fatty liver demonstrated significantly higher HOMA-IR, LH/FSH ratio and serum compared to those without fatty liver (all p<0.001). High-glycemic diet, fasting insulin, BMI >25 kg/m² WHR >0.85 and high CI were identified as significant independent biomarkers of fatty liver as well as visceral/central obesity. Increased ALT:AST ratio, elevated-TG and decreased-SHBG were identified as significant biomarkers of metabolic-hormonal disturbance, termed PMOS. Conclusion: This study highlights a high prevalence of fatty liver and metabolic–hormonal disturbances in PCOS/PMOS, primarily mediated by insulin resistance, hyperandrogenism and unhealthy dietary patterns. The findings underscore the necessity of early metabolic screening and lifestyle interventions to mitigate long-term reproductive and metabolic risks. Key words: PCOS, PCOM, NAFLD, Insulin Resistance, LH/FSH Ratio, Hyperandrogenism, High-Glycemic Diet, Fatty Liver

Read PDF

Similar papers

Open access Aug 2026

Polycystic Ovary Syndrome Is Associated with Fatty Pancreas Disorder: A Case–Control Study in Non-Diabetic Women

Background/Objectives: Polycystic ovary syndrome (PCOS) is closely associated with insulin resistance, metabolic syndrome (MetS), and non-alcoholic fatty liver disease (NAFLD); however, whether fatty pancreas disorder is also more common in PCOS remains insufficiently clarified. This study aimed to compare the frequenc...

Halil Severoglu, F. Ateş, Hüseyin Durukan · 0 citations
Open access Aug 2026

Obesity, Insulin Resistance, and Infertility in Women with Polyendocrine Metabolic Ovarian Syndrome: A Retrospective Cohort Study at a Tertiary Referral Medical Center in Qatar

Background: Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously known as Polycystic Ovary Syndrome (PCOS), is one of the most common endocrine disorders affecting women of reproductive age and represents a major cause of infertility worldwide. It is associated with hormonal imbalance, ovulatory dysfunction, and...

Tahani Ibrahim Alotoum, Husam Qush, R. Al-Ghanem et al. · 0 citations
Open access Sep 2026

Polycystic ovary syndrome, insulin resistance, and bone health in Saudi women: a cross-sectional study

The substantial metabolic burden of IR in Saudi women with PCOS and its association on hormonal profiles are highlighted, highlighting the importance of early IR identification and management to mitigate long-term health complications in PCOS.

Mai Albaik, F. McGuigan, Ahmed E. Altyar et al. · 0 citations
Open access Aug 2026

Common inflammatory markers in polycystic ovary syndrome (PCOS): a BMI-matched case–control study.

Background: Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder associated with low-grade inflammation.  Aim: To compare inflammatory markers between women with PCOS and age- and BMI-matched controls and assess their metabolic associations.  Materials and Methods: This hospital-based case–control...

S. Jinger, Priyanka Songara, Kshatrapal Dabi · 0 citations
Open access Sep 2026

Association of prolactin with cardiometabolic risk markers in women with polycystic ovary syndrome: a phenotype-based analysis

Compared with controls, women with PCOS had higher body weight, body-mass index, waist circumference, waist circumference, triglyceride levels, insulin resistance-related parameters, triglyceride-glucose (TyG) Index, lipid accumulation product (LAP), and Atherogenic Index of Plasma (AIP), whereas high-density lipoprote...

Hatice Çalışkan Burgucu, Emel Yılmaz Kaya, Ayşen Yümlü et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.